Gender Differences in Adipocyte Metabolism and Liver Cancer Progression by Otto K.-W. Cheung & Alfred S.-L. Cheng
fgene-07-00168 September 20, 2016 Time: 11:2 # 1
REVIEW
published: 20 September 2016
doi: 10.3389/fgene.2016.00168
Edited by:
Rui Henrique,
Portuguese Oncology Institute Porto,
Portugal
Reviewed by:
Suhasni Gopalakrishnan,
University of Southern California, USA
Giuseppe Calamita,
University of Bari Aldo Moro, Italy
*Correspondence:
Alfred S.-L. Cheng
alfredcheng@cuhk.edu.hk
Specialty section:
This article was submitted to
Epigenomics and Epigenetics,
a section of the journal
Frontiers in Genetics
Received: 19 July 2016
Accepted: 05 September 2016
Published: 20 September 2016
Citation:
Cheung OK-W and Cheng AS-L
(2016) Gender Differences
in Adipocyte Metabolism and Liver
Cancer Progression.
Front. Genet. 7:168.
doi: 10.3389/fgene.2016.00168
Gender Differences in Adipocyte
Metabolism and Liver Cancer
Progression
Otto K.-W. Cheung1 and Alfred S.-L. Cheng1,2*
1 School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China, 2 State Key Laboratory of
Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
Liver cancer is the third most common cancer type and the second leading cause
of deaths in men. Large population studies have demonstrated remarkable gender
disparities in the incidence and the cumulative risk of liver cancer. A number of
emerging risk factors regarding metabolic alterations associated with obesity, diabetes
and dyslipidemia have been ascribed to the progression of non-alcoholic fatty liver
diseases (NAFLD) and ultimately liver cancer. The deregulation of fat metabolism
derived from excessive insulin, glucose, and lipid promotes cancer-causing inflammatory
signaling and oxidative stress, which eventually triggers the uncontrolled hepatocellular
proliferation. This review presents the current standing on the gender differences in
body fat compositions and their mechanistic linkage with the development of NAFLD-
related liver cancer, with an emphasis on genetic, epigenetic and microRNA control. The
potential roles of sex hormones in instructing adipocyte metabolic programs may help
unravel the mechanisms underlying gender dimorphism in liver cancer and identify the
metabolic targets for disease management.
Keywords: adipocyte, adipokine, adiponectin, epigenetic, gender dimorphism, hepatocellular carcinoma, leptin,
metabolism
INTRODUCTION
Liver cancer is currently the third most common cancer type and the second leading cause of
deaths in men (521,000, 6.4% of the total, per annum; Bray et al., 2013; Ferlay et al., 2015; GBD
2013 Mortality and Causes of Death Collaborators, 2015). Despite the use of aggressive treatments,
the 5-years survival rate for patients with liver cancer only varies around 10% and will remain
a global health concern, especially in Asian countries (Farazi and DePinho, 2006; Bray et al.,
2013; Villanueva and Llovet, 2014). Hepatocellular carcinoma (HCC) has accounted for a majority
(90%) of liver cancer cases. Risk factors leading to HCC comprise a medical history of chronic
liver diseases, including liver cirrhosis, hepatitis, alcoholic and non-alcoholic fatty liver diseases
(AFLD and NAFLD, respectively). NAFLD is characterized by abnormal accumulation of TAG in
hepatocytes under metabolic and viral stimulation and it is reported to be one of the most prevalent
causes of chronic liver diseases in Western countries, constituting an estimated prevalence of 20–
40% (Tiniakos et al., 2010; Chalasani et al., 2012). NAFLD may progress into NASH, cirrhosis and
ultimately HCC (Tian et al., 2013).
Emerging evidence has ascribed the development of liver cancer to obesity and type 2 diabetes
(Welzel et al., 2013). The World Health Organization (WHO) categorizes a body mass index
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(BMI) ≥ 25 kg/m2 as overweight and a BMI ≥ 30 kg/m2 as
obese. From 1980 to 2008, the worldwide prevalence of obesity
has doubled, according to the statistics of WHO (Finucane et al.,
2011). Obesity does not only induce cancer-causing chronic
inflammation, but also cause alterations in the endocrine system
(Baffy et al., 2012; Vongsuvanh et al., 2012), which might
altogether contribute to the increased risks for the development
of NAFLD and HCC (Vanni and Bugianesi, 2014; Chang et al.,
2016). Due to the difficult differentiation in a large scale, separate
global estimates of prevalence for types 1 and 2 diabetes are not
available (NCD Risk Factor Collaboration [NCD-RisC], 2016).
The skyrocketing increase in the number of diabetic patients
estimated by WHO (fourfolds) from 1980 to 2014 has coincided
with the current increase of liver cancer incidence (NCD Risk
Factor Collaboration [NCD-RisC], 2016). Indeed, a recent study
has as well estimated that patients with a history of diabetes
and/or obesity will exhibit a 2.47-fold higher liver cancer risk
(Welzel et al., 2013). The present epidemic of fat-associated
metabolic syndromes is positively correlated to the increasing
trend of HCC all over the world.
Sexual dimorphism is the biological inequality between males
and females in disease initiation and progression. Deregulated
signaling of sex hormones, i.e., androgen in males and estrogens
in females, is believed to be one of the drivers of sexual
dimorphism in HCC. The male-to-female ratio averages between
2:1 and 7:1 in virus and NAFLD-related HCCs (Parkin et al., 2006;
Guerrero et al., 2009; El-Serag, 2012; Tian et al., 2013). Recent
population-based studies have consistently demonstrated much
higher risk of HCC in obese men. In a prospective study including
more than 900,000 adults, it was found that men with a BMI
of 35 kg/m2 exhibited a dramatic 4.52-fold increase in relative
risk of death from liver cancer, while a modest 1.68-fold increase
was observed in women (Calle et al., 2003). A cohort study of
5.24 million adults in UK has further confirmed the significant
modulation of HCC incidence by gender (Bhaskaran et al., 2014).
More recently, a multi-ethnic cohort study has shown that BMI
was strongly associated with HCC in Japanese, white, and Latino
men (Bhaskaran et al., 2014). The multi-regional epidemiological
studies have all revealed the high male-to-female ratio in both
HCC incidents and risks, raising a question in how two genders
differ in the pathogenesis of HCC.
While NAFLD-associated HCC is closely associated with
deregulation in fat metabolism, gender dimorphisms may occur
in our adipose homeostasis. Differences in body fat composition
rather than BMI were suggested to be true determinants of
HCC prognosis. Indeed, visceral adiposity can independently
predict mortality in patients with HCC (Setiawan et al., 2016).
Coincidentally, visceral fat accounts for a strikingly larger
proportion of body fat in men than in women, indicating the
potential importance of the studies into HCC-associated fat
metabolism and the corresponding gender disparities (Fujiwara
et al., 2015; Setiawan et al., 2016).
Current studies in the gender disparities in HCC primarily
focus on the deregulated signaling pathways and metabolism
in hepatocytes. While abnormal fat metabolism plays a crucial
role in the onset of HCC, the dramatic differences in the
body fat distribution and the adipocyte depot-specific roles
in different genders are seldom taken into account. We are
presenting the current understanding of the gender disparities in
the body fat composition and glycerol metabolism, and discuss
the mechanisms by which these metabolic alterations potentially
contribute to the contrasting number of incidents of HCC in
males and females.
ADIPOCYTE METABOLISM AND HCC
Metabolic syndromes are closely associated with two types
of white adipose tissues, visceral adipose tissue (VAT) and
subcutaneous adipose tissue (SCAT). Gender disparities occur
in the distribution and composition of body fat, which may
help explain the cause for the strikingly higher HCC incidence
in men. VAT differs from SCAT in terms of anatomy, cellular
functions, molecular compositions, endocrine functions, and
their response of insulin and other hormones. Anatomically,
VAT and SCAT are categorized by their corresponding location
of depots. Visceral fat is defined as the fat depots around the
abdominal organs including the liver and the small intestine;
subcutaneous fat, which is located at the femerogluteal regions,
back and anterior abdominal wall, represents the physiological
buffer for excess energy intake and accounts for around 80% of
our total body fat (Wajchenberg, 2000). Visceral fat accumulates
as the age increases in both genders (Wajchenberg, 2000). As
mentioned, men possess nearly 30% more visceral fat than
women, suggesting the promising field to study in resolving
the relationship among adipocyte physiology, genders and HCC
(Fujiwara et al., 2015; Setiawan et al., 2016). Regarding their
particular locations, visceral fat and subcutaneous fat employ
different drainage routes of blood. Venous blood from VATs
is circulated directly to the liver via the portal vein while
subcutaneous fat venous blood is drained through systemic
veins (Klein, 2004). Adipocytes are responsible for the storage
of excess energy intake and the absorption of free fatty acids
(FFAs) and triglycerides. Adipocytes get dysfunctional when
they get hypertrophic (Ibrahim, 2010). Adipocytes in VAT are
generally bigger in size, hyperlipolytic, insulin-resistant and are
molecularly different from those in the subcutaneous regions
(Ibrahim, 2010). The accumulation of visceral fat in the omental
region promotes insulin resistance and its associated liver injury.
The deregulated release of FFAs and glycerol from visceral
adipocytes can also contribute to the onset of HCC. Considering
the fact that visceral fat accumulates more in males and it
causes a tumor-promoting condition in the liver, it is logical to
postulate the intriguing relationship between fat metabolism and
the gender dimorphisms in HCC.
The adipose tissue comprises multiple cell lineages including
adipocytes, preadipocytes, vascular and neural cells and more
importantly the immune cells (Ibrahim, 2010; Gregor and
Hotamisligil, 2011). Early studies reported the increase in
infiltration of inflammatory macrophages in VAT, which thus
causes insulin resistance in mice and human (Weisberg et al.,
2003; Bruun et al., 2005; Michaud et al., 2012). C-C motif
chemokine receptor 2-knockout (Ccr2-KO) mice attributed
insulin resistance in diet-induced obesity to the shift of from
Frontiers in Genetics | www.frontiersin.org 2 September 2016 | Volume 7 | Article 168
fgene-07-00168 September 20, 2016 Time: 11:2 # 3
Cheung and Cheng Genders, Adipocyte Metabolism and HCC
pro-inflammatory M1 macrophages into alternatively activated
M2 macrophages and the reduction of anti-inflammatory
cytokine interleukin-10 (IL-10) (Lumeng et al., 2007). The
increased infiltration of inflammatory macrophages in visceral
fat causes insulin resistance via the nuclear factor-κB (NF-κB)
pathway (Lê et al., 2011). In general, visceral fat accumulation is
accompanied with the increase in M1 macrophage population,
nurturing an elevated local inflammation and a pro-carcinogenic
environment within the adipose tissue. The accumulation of
activated M2 macrophages in the abdominal adipose tissue
remove the protective effect of IL-10 against tumor formation.
The increased infiltration could also elevate the liver burden and
gradually promotes HCC.
Both levels of visceral fat and HCC risks positively correlate
with age and a masculine gender. In view of the harmful
effects of visceral adiposity, the contrasting levels of visceral fat
accumulation in males and females may help explain the gender
disparities in immune responses (Klein and Flanagan, 2016) and
HCC development (Tian et al., 2013).
Visceral Adipose Tissue and HCC
Obesity is a heterogeneous disorder, with which obese individuals
exhibit a wide range of body fat distribution and the associated
metabolic profiles. Obesity is associated with excess body fat.
Adipose tissue has long been considered as an inert storage
of energy while more recent studies have pointed out its role
in the immune and endocrine regulation (Cabia et al., 2016).
White adipose tissue can be subdivided into VAT and SCAT
according to its distribution. VAT mainly deposits around
the abdominal viscera in mesentery and omentum and is
responsible for the “central obesity” phenomenon in which
individuals have a greater risk of type 2 diabetes, cardiovascular
diseases and obesity-related cancer (McKeigue et al., 1991;
Pérez-Pérez et al., 2009; Ibrahim, 2010; Wolin et al., 2010).
VAT and SCAT present very distinct physiological functions.
VAT acts as a metabolically active endocrine organ secreting a
number of adipokines for regulatory purposes (Ibrahim, 2010).
Visceral adiposity has been complicated with negative effects
including insulin resistance and the elevated production of pro-
inflammatory molecules leptin (LEP), resistin, tumor necrosis
factor-α (TNF-α), IL-6, hypoxia-inducible factor 1 (HIF-1) and
adipocyte fatty-acid binding protein (A-FABP) (Weisberg et al.,
2003; Wisse, 2004; Gregor and Hotamisligil, 2011; Spoto et al.,
2014; Petrangeli et al., 2016). Excess absorption of fat from
the diet enlarges adipocytes and stimulates the release of FFAs
(Ibrahim, 2010) (Figure 2). Visceral fat is considered as a major
source of FFAs in the portal vein, which can cause liver fat
accumulation and the development of NAFLD (Paschos and
Paletas, 2009). Adiposity has also been reported to associate
with cancer-causing phenotypes including secretion of immune
cell-attracting molecules (e.g., monocyte chemoattractant protein
1, MCP-1), angiogenesis, cellular senescence through microbial
metabolites (e.g., deoxycholic acid, DCA), lipolysis and decreased
production of adiponecitin (Yu et al., 2006; Bruemmer, 2012;
Duan et al., 2013; Ferrente, 2013; Yoshimoto et al., 2013)
(Figure 2). FFAs-induced inflammation and insulin resistance
leads to pathogenic endoplasmic reticulum stress and eventually
fosters a tumor-promoting, low-grade chronic inflammatory
microenvironment in the liver (Ohki et al., 2009; Zhao and
Lawless, 2013). A particular form of FFAs, linoleic acid, which
is usually accumulated in NAFLD, has recently been ascribed to
the disruption of mitochondrial function, oxidative damage and
the selective loss of intrahepatic CD4+ T cells (Ma et al., 2016).
Adiposity is closely associated with the immune cell population in
liver. Alongside the chronic inflammation caused by the increase
in FFA release, the loss of CD4+ T cells potentially results in the
failure of recruiting innate immune cells to kill pre-malignant
senescent hepatocytes and suggesting the role of an inflammatory
microenvironment in HCC initiation. An increased population
of B lymphocytes was found recruited in adipose tissue in
obese subjects (Figure 2). B cells in obese mice favored the
secretion of pro-inflammatory cytokines IL-6 and suppressed
anti-inflammatory cytokines IL-10 (Winer et al., 2011). High-
fat diets raised B cell population and caused insulin resistance
in mice (Winer et al., 2011). VAT accumulation has also been
proposed as an independent risk factor for HCC since visceral
fat accumulation was positively correlated to the recurrence of
HCC and the severity of fatty liver in NAFLD patients, but,
interestingly, not SCAT (Ohki et al., 2009). Cohort studies using
computerized tomography (CT) to measure VAT have shown
that visceral fat accumulation enhances the severity of hepatic
inflammation and fibrosis in NASH, HCC risks as well as the
recurrence of HCC after curative treatment (van der Poorten
et al., 2008; Ohki et al., 2009; Vongsuvanh et al., 2012; Schlesinger
et al., 2013). Furthermore, visceral fat accounted up to 10–20% of
the total fat in men and 5–8% in women, whereas subcutaneous
fat accounts for a significantly larger portion of total body fat
in women as shown in different studies (Bhaskaran et al., 2014;
Setiawan et al., 2016) (Figure 1). Emerging evidence in visceral fat
accumulation points toward tumor formation and the differential
body fat composition in males and females potentially results in
gender disparities in HCC risks. The higher level of metabolically
active VAT in males nurtures a pro-carcinogenic environment
while the higher SCAT level in females may, on the other hand,
offers a buffering and protective effect against HCC formation.
Regarding the tumor-promoting properties of visceral fat and the
coinciding gender dimorphisms in both liver cancer and visceral
adiposity, the following session will focus on the underlying
mechanisms (Figure 2).
In short, the higher level of VAT in males contributes
to the likelihood of HCC initiation either by releasing
pro-inflammatory adipokines, metabolites or immune cell
infiltration.
Adipokines and HCC
Adipokines are peptides, proteins, and cytokines synthesized
by the adipose tissue. Over 75 adipokines have been identified
in adipose tissue, while only some of them are associated
with carcinogenesis, especially the development of liver cancer
(Trayhurn and Wood, 2004; Wood et al., 2009; Zhao and Lawless,
2013; Cabia et al., 2016). Classical examples of adipokines
synthesized by dysfunctional obese adipose tissue are usually
involved in localized chronic inflammation. Enlarged adipocytes
in VAT liberates FFAs to stimulate adipose tissue macrophages
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FIGURE 1 | Gender dimorphism occurs in the altered metabolic pathways that can lead to the progression of HCC. Visceral adiposity can be observed
more commonly in men and nurtures a pro-carcinogenic microenvironment that promotes HCC initiation.
FIGURE 2 | Visceral adiposity increases the release of pro-inflammatory adipokines and reduces the protective counterpart, causing immune cell
infiltration, liver injury, and the subsequent pathological syndromes. The increase in the release of FFAs and glycerol to the liver from visceral fat also
promotes lipid peroxidation and thus increases HCC risks. MDSCs: myeloid-derived suppressor cells.
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to produce TNF-α, which in turns activate adipocytes to
undergo lipolysis and secret multiple cancer-causing adipokines
(Ibrahim, 2010; Michaud et al., 2012). MCP-1 is secreted
by adipocytes to recruit macrophages and myeloid-derived
suppressor cells (MDSCs) to local tissue and further worsen
chronic inflammation (Yu et al., 2006; Okwan-Duodu et al., 2013)
(Figure 2). Moreover, hypertrophied adipocytes are exposed to
a hypoxic condition in which there is an elevated production
of HIF-1, leading to the infiltration of macrophages and the
secretion of adipokines (Trayhurn et al., 2008) (Figure 2). The
release of a pro-inflammatory cytokine IL-6 from hepatic stellate
cells is associated with an increased level of FFAs in VAT
(Wieckowska et al., 2008; Yoshimoto et al., 2013). IL-6 is also
associated with insulin resistance, fibrosis and tumorigenesis
involving the activation of STAT3, Akt, Erk, JNK pathways
(Wieckowska et al., 2008; Park et al., 2010).
Leptin is an important adipose-derived hormone involved
in energy homeostasis, immune responses, angiogenesis,
and insulin signaling (Franckhauser et al., 2006). Leptin
overexpression was found responsible for TNF-α and IL-6-
related chronic inflammation, insulin resistance, liver fibrosis,
and HCC development (Ikejima et al., 2001; Wang et al.,
2001; Franckhauser et al., 2006; Chen et al., 2007; Tsochatzis
et al., 2008). Leptin has been reported to cause proliferation
of HCC cells by altering the activity of cyclin D1 and the
apoptotic gene, Bax (Chen et al., 2007). Leptin is also one of
the reported biomarkers for early recurrence of HCC after
treatment (Watanabe et al., 2011). Women require twice as
high circulating leptin levels to maintain normal body weight
and are more resistant to leptin activity than men do (Licinio
et al., 1998). The resistance to leptin in women potentially
reduces the corresponding harmful effects. A reduction in leptin
sensitivity may reduce cytokine-induced inflammation and
insulin resistance. It is suggested that women are subject to a
lower HCC risk due to a lower sensitivity to leptin.
Adiponectin is considered to play a protective role in
cancer progression involving anti-inflammation, sensitization of
insulin signaling and anti-angiogenesis. Adiponectin induces the
production of IL-10, working together to inhibit inflammatory
factors like IL-6 by inhibiting the NF- κB pathway cascade
(Ibrahim, 2010; Lira et al., 2012). Other anti-cancer mechanisms
of adiponectin include promoting apoptosis in HCC cells
and inhibit cell migration by inhibiting Akt/STAT3 signal
transduction (Sharma et al., 2010; Lira et al., 2012). Contradictory
results showed the cancer-promoting role of adiponectin in
HCC patients. A significantly higher level of serum adiponectin
is reported in HCC patients and was also found guilty
for tumor growth (Chen et al., 2012; Sadik et al., 2012).
Since the metabolic profiles in HCC patients have been
severely altered, the implicit role of adiponectin regarding
HCC development requires further investigations. Despite
all these, it is generally believed that men with a higher
level of visceral fat accumulation are more subject to a
procarcinogenic microenvironment. Hormonal influences on
adipocyte homeostasis could be one of the reasons for the
differential visceral fat accumulation and the differences in
adipokine production.
GENDER DIMORPHISM IN ADIPOCYTE
METABOLISM
Sex Hormones and Adipocyte
Metabolism
Visceral fat deposition is significantly higher in males than in
females whereas subcutaneous fat accumulates more in females
(Ibrahim, 2010). Having a similar total fat and BMI, males
showed a higher visceral fat and liver fat content than females
in multiple datasets (Bhaskaran et al., 2014; Setiawan et al.,
2016). Obvious gender dimorphism was also observed in both
diet-related liver diseases and HCC initiation (Chang et al.,
2016). Visceral fat actively secrets oncogenic adipokines, leading
to chronic inflammation and contributes to liver cancer. The
disparities of liver cancer and visceral fat deposition potentially
originate from high androgen receptor (AR) density (Freedland,
2004). The increase in body visceral fat and the decrease in
body subcutaneous fat as the age increases, coinciding with
the increase with HCC incidence (Björntorp, 1995). Estrogen
promotes the accumulation of subcutaneous fat and is protective
against inflammation (Ibrahim, 2010). After menopause, the rise
of body VAT in women is related to the deficiency of estrogen
(Björntorp, 1995; Freedland, 2004). Signaling pathways involving
sex steroids contribute to the differential secretion of cancer-
causing adipokines in men and women, thus leading to a higher
risk of HCC in men. Potential sexual dimorphism in HCC is also
caused by the differential recruitment of Foxa-1/2 transcription
factors and the corresponding androgen and estrogen receptors,
showing the involvement of steroid hormones in liver cancer
development (Li et al., 2012). AR and ER can both act as
transcription factors altering chromatin accessibility and gene
transcription in HCC (Li et al., 2012). Although limited studies
using chromatin-immunoprecipitation-sequencing (ChIP-seq)
have been done on adipocytes, it is postulated that the differential
binding profiles of AR and ER in visceral fat and subcutaneous
fat can help unveil the underlying mechanisms of androgen and
estrogen in visceral adiposity and the subsequent side effects. The
potential links may help understand the differences of adipokine
profiles in men and women and thus explain how men get more
prone to HCC initiation.
Estrogen
Estrogen and estrogen receptor (ER) signaling have been found
to have a protective role in HCC initiation and progression
via the IL-6/STAT inflammatory pathways (Naugler et al.,
2007; Yang et al., 2012). One of the anticancer adipokines
adiponectin is expressed at a higher level in women than in
men (Laughlin et al., 2006). Estrogen replacement therapy helps
decrease adiponectin circulation in postmenopausal women
(Kunnari et al., 2008). It is reported that adiponectin is
inversely associated with the incidence of multiple types of diet-
related cancer (Housa et al., 2006). Adiponectin is associated
with anti-inflammation, increasing insulin sensitivity and anti-
angiogenesis, which coincides with the protectively role of
estrogen signaling (Tworoger et al., 2007; Ibrahim, 2010).
A reduction of body estrogen after menopause is frequently
Frontiers in Genetics | www.frontiersin.org 5 September 2016 | Volume 7 | Article 168
fgene-07-00168 September 20, 2016 Time: 11:2 # 6
Cheung and Cheng Genders, Adipocyte Metabolism and HCC
followed by an increase in body visceral fat (increase in size of
adipocytes), hyperinsulinemia and increase in IL-6 production
(Freedland, 2004). Estrogen offers a protective effect against
metabolic deregulation and HCC. It is suggested that a reduction
in the endogenous estrogen level causes a drop in adiponectin
in postmenstrual women. The physiological mechanisms of
estrogen on the release of adiponectin are a potential explanation
for the gender dimorphism of HCC.
Androgen
Regional androgen concentration in VAT suggests a depot-
specific effect on adipocyte functions and metabolism
(Bélanger et al., 2006). Androgen excess in female mice using
5α-dihydrotestosterone (DHT) treatment induced an increase
in visceral fat deposition, via an altered hypothalamic axis
(Nohara et al., 2014). The complicated role of androgen signaling
in body fat distribution and adipocyte functioning has long
annoyed scientists for decades. Early studies revealed results on
a reduced circulating androgen levels with visceral fat deposition
(Garaulet et al., 2000; Tsai et al., 2004; Kraus et al., 2015).
Androgen was shown to have a suppressive effect in adiponectin
level consistently in cell lines, animal models, and human
epidemiological studies (Nishizawa et al., 2002; Lanfranco et al.,
2004; Isobe et al., 2005; Page et al., 2005). Such phenomenon
explains how androgen undermines the anti-inflammatory
effects of adiponectin and develops chronic inflammation in the
liver. Regarding the regulation of androgen on genes involved
in adipogenic genes, recent studies have discovered the role of
microRNA miR-375 in adipocyte differentiation and distribution.
Androgen treatment in preadipocytes could downregulate miR-
375 expression and increase the level of adiponectin receptor 2
(ADIPOR2), which might help understand the mechanisms of
how testosterone deficiency could lead to insulin resistance and
visceral fat accumulation (Kraus et al., 2015). Generally, visceral
fat has a high density of AR, which allows testosterone to amplify
its own effect by raising AR expression, inhibiting lipoprotein
lipase and the uptake of FFAs (Wajchenberg, 2000; Freedland,
2004). As men age, the bioavailability of testosterone declines and
leads to the deposition of visceral fat. Yet, the case is opposite in
women who exhibit an increase in androgen level released from
the ovary when they are complicated with hyperinsulinemia and
it is known as the polycystic ovary syndrome (Wajchenberg,
2000; Freedland, 2004). In vivo and in vitro studies of leptin
production varied greatly. Adipocytes from different locations
reacted differently to androgen in vivo and in vitro (Machinal
et al., 1999). The difficulty of local application of androgen has
long limited the physiological studies of how androgen affects
a particular region of adipocytes and the following pathologies.
Contrary to its involvement in HCC, androgen appears to inhibit
visceral fat accumulation and the complicated association among
androgen, visceral fat accumulation and liver cancer needs
further investigation.
In short, the androgen to estrogen ratio determines the leptin
and adiponectin levels and visceral adiposity. A higher androgen
to estrogen ratio is associated with a respective higher leptin and
lower adiponectin ratio in both genders. The high androgen to
estrogen ratio is linked to metabolic syndromes and it is also
predicted such phenomenon is one of the culprits for HCC
initiation.
Gender-specific Single Nucleotide
Polymorphisms in Adipose Tissue
The large discrepancies in fat distribution and homeostasis in
males and females imply potential genetic predispositions. Single
nucleotide polymorphisms (SNPs) are enriched for expression
of loci of quantitative traits and may alter gene expression
(ENCODE Project Consortium, 2012). This mechanism has
been argued to be a major driver in disease susceptibility by
genetically altering the susceptibility of DNA methylation and
thus affecting gene expression (Martínez et al., 2014). It has
been demonstrated for obesity, insulin resistance, inflammation,
oxidative stress, and hypoxia, which are all driver components of
HCC initiation (Martínez et al., 2014). Such mechanism is also
reported to be cell type-specific (Fairfax et al., 2012). Sex-specific
SNPs are found potentially responsible for fat distribution and
inflammation (Sung et al., 2016; Wang et al., 2016). Martínez
et al. (2014) have summarized a panel of candidate genes
which are epigenetically regulated through DNA methylation and
are involved in lipid homeostasis, including CEBPA, PPARA,
LEP, MC4R, NPY, POMC, FTO, ADIPOQ, GLUT4, INS, HIF1A,
IFNG, TNF, FASN, NR3C1, and UCP1 (Martínez et al., 2014).
Among all the epigenetic targets, sexual dimorphisms in the
SNPs can be identified, including the Adiponectin, C1Q And
Collagen Domain Containing gene (ADIPOQ) and the leptin
gene (LEP), which, respectively, encode for crucial players in
visceral adiposity and liver cancer initiation, adiponectin and
leptin (Figure 3).
ADIPOQ
ADIPOQ has a length of 1.579 kb and contains three exons, in
which the transcription start site is located at exon 2 (Mackevics
et al., 2006). Several SNPs inside the ADIPOQ gene have been
associated with adiponectin serum levels, body adiposity and
other metabolic alterations, rendering it a potential player in
obesity and metabolic syndromes (Mackevics et al., 2006; Dolley
et al., 2008; Bostrom et al., 2009). Association studies of ADIPOQ
polymorphisms, adiponectin levels and obesity phenotypes using
samples of African American population from the Jackson Heart
Study (JHS) cohort (Riestra et al., 2015). Data collected from
2968 participants (1131men and 1837 women) revealed gender-
specific association between SNPs rs6444174, rs1403697, and
rs7641507 with serum adiponectin levels in women but not men
(Riestra et al., 2015). SNPs in ADIPOQ have also been reported to
be associated with type 2 diabetes (Peters et al., 2013). SNPs at the
adiponectin gene appear differently in men and women affecting
circulating adiponectin, which may cause different adipocyte
homeostasis and thus affecting the liver functions in a sex-specific
manner.
Leptin (LEP)
DNA polymorphism in the leptin gene is associated with
tumorigenesis of multiple cancer types, such as lung cancer,
lymphoma, thyroid cancer, and colon cancer (Slattery et al.,
2008; Liu et al., 2014; Unsal et al., 2014; Marcello et al., 2015).
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FIGURE 3 | Protective single nucleotide polymorphisms (SNPs) in ADIPOQ and LEP genes that lead to differential serum adiponectin and leptin levels
occur frequently in females. A respective higher adiponectin and a lower leptin level can be found in female subjects. SNPs in ADIPOQ and LEP genes potentially
reduce HCC risks and development in women through inflammatory and oncogenic pathways.
LEP is primarily expressed in differentiated adipocytes of white
adipose tissue, and the hormone leptin it encodes for, plays a role
in the regulation of food intake and the expression of energy-
regulating peptides. LEP has been proposed as a culprit for
obesity-induced cancer because it displays epigenetic variation
and is involved in energy homeostasis, immune responses,
angiogenesis and insulin signaling (Franckhauser et al., 2006).
Deregulated production of leptin or its receptor is highly
associated with HCC development (Chen et al., 2007). Some
Leptin G-2548A (rs7799039) polymorphism showed association
with serum leptin level and obesity in young females only
(Ben Ali et al., 2009; Shahid et al., 2015) (Figure 3). Since
leptin is closely related to insulin signaling and inflammation,
it is considered as a strong risk factor in obesity-related
cancer. The gender dimorphism in the leptin gene may alter
leptin secretion in adipocytes and eventually alter the cancer
risk in different genders (Tobi et al., 2009). On the other
hand, when the preadipocytes mature, the gene is activated
by DNA demethylation (Melzner et al., 2002). Differences in
the methylation status of the LEP promoter influence LEP
expression in vitro, which approves the functional role of DNA
methylation on leptin secretion in adipocytes (Rankinen et al.,
2006). The establishment of epigenetic profiles is susceptible to
maternal diets during early development (Dahlhoff et al., 2014).
Female mice undertaking high-fat diets affected the offspring
genes involved in fatty liver disease, lipid droplet size regulation
and body fat expansion (Dahlhoff et al., 2014). The harmful
effects of maternal diets on offspring have been reported to
be organ-specific, gender-specific and remain at different life
stages. The adult male offspring exhibited traits related to liver
disease development overweight, insulin resistance, high leptin
levels and hepatic steatosis but not the female counterpart,
proving the possibility of gender-specific expression of leptin
(Dahlhoff et al., 2014; Ge et al., 2014; Allard et al., 2015)
(Figure 4).
Single nucleotide polymorphisms in the genes controlling
expression of key adipokines leptin and adiponectin exert
differential effects on males and females. Metabolic syndromes
including type 2 diabetes and excess fat deposition could be
caused by the differential expressions of ADIPOQ and LEP genes
in males and females as a result of the respective SNPs.
GWAS studies rely heavily on the associations of gender-
specific SNPs with metabolic traits such as insulin, leptin,
adiponectin levels to support the fact that certain genetic
predispositions leading to visceral fat accumulation and the
release of leptin increases the risks of metabolic complications.
The following challenge now is to understand the biological
functions of those genes and how they are regulated differentially
in males and females. In the aspect of genetics, mRNA expression
profiles of such genes can be correlated with BMI, body
fat distribution and our gender. Other possible mechanisms
include epigenetic regulation via DNA methylation or histone
modifications may be responsible for the association of the
aforementioned traits with gender.
Epigenetic Regulation in Adipose Tissue
Epigenetic regulation of genes are considered to be important
for disease pathogenesis since it is believed to translate
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FIGURE 4 | Hypermethylation of LEP promoter in female offspring offers a protective effect against maternal high-fat diets by lowering leptin
production in mice. Maternal high-fat diets affect offspring’s epigenetic regulation on the LEP gene. Obesogenic environments during the pre-conceptional period
and the early phase of development led to a lower methylation state of the LEP promoter in male rodent offspring than their female counterparts. The higher leptin
production in male offspring was also associated with overweight, insulin resistance and hepatic steatosis, which could help explain the gender dimorphism in leptin
production and the development of liver diseases and HCC.
environmental factors into phenotypic traits through alteration
in the transcriptome (Fraga et al., 2005; Sandovici et al., 2011).
DNA Methylation
One of the many epigenetic mechanisms, methylation of CpG
dinucleotides is proved to play crucial roles in the decision
of cell fates, tumorigenesis and multiple cellular functions
(Esteller, 2007; Baylin and Jones, 2011). DNA methylation
usually occurs at CpG-rich regions and is often associated
with gene repression (Bird, 2002). Epigenetics can provide
insights for the understanding of chronic disease onset in
adults, which interact with external stimuli like dietary intake
and nutritional processes. Epigenetic regulations are believed
to translate physiological impacts into altered gene expressions.
Many genomic studies have reported the gene expression
patterns in VAT, yet the differentially expressed genes may
be functionally associated with visceral fat dysfunction and
metabolic syndromes, including adipose tissue macrophage-
specific genes and insulin resistance-related genes (Bouchard
et al., 2007; Blüher, 2009; Hardo et al., 2011; Klimcakova
et al., 2011). Epigenetic mechanisms may contribute to the
variability of the gene expression and the different components
of metabolic syndromes. Transcriptional CpG-island promoter
hypermethylation or global DNA methylation may affect
the expression of genes controlling adipokine secretion, fat
distribution, macrophage infiltration and insulin sensitivity.
A recent genome-wide analysis of CpG methylation states of
blood and adipose tissue from 479 individuals has revealed
the association between DNA methylation and BMI (Dick
et al., 2014). Data showed that the methylation level at three
HIF3A sites was strongly correlated to BMI in adipose tissue,
i.e., an increase in BMI was associated with an increase in
methylation level at HIF3A sites. The HIF3A gene could not
only respond to oxygen content locally, but it also played a
role in cellular response to insulin and glucose and accelerated
adipocyte differentiation in acquired obesity (Heidbreder et al.,
2007; Hatanaka et al., 2009; Robciuc et al., 2011). Obesity has
been reported to increase a global mean DNA methylation in
adipocytes (Arner et al., 2015; Benton et al., 2015). Exercise
can significantly influence the DNA methylation patterns in a
genome-wide manner (Rönn et al., 2013). Post-obese patients
experienced a global DNA hypomethylation and differential
methylation of adipogenesis genes (Dahlman et al., 2015). More
DNA methylation in adipocytes can regulate different genes
related to hypoxia and insulin sensitivity, providing a new scope
for investigating the relationship between adipocyte homeostasis
and liver cancer development.
Recent studies have also take advantage of cell lines and
human mesenchymal stem cells in the study of DNA methylation
in the transcriptional activation of leptin and adiponectin genes
(Kuroda et al., 2016; Zhang W. et al., 2016). On top of this,
Ambati et al. (2016) have also demonstrated the differential
expressions of genes encoding for epigenetic regulators in VAT
and SCAT in mice. The adipocyte nuclei were immuno-captured
from VAT and SCAT to resolve the difficulties of isolating mature
adipocytes from adipose tissue. The differential expressions of
chromatin remodeler proteins involved in DNA methylation
and histone modification shed light on the studies of epigenetic
regulation of gene expressions in adipose tissues, promoting the
study in the gender disparities in adipocyte homeostasis through
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epigenetics. Possible mechanisms of such disparities may include
the binding of transcription factors like AR and ER alongside
other pioneer factors that affect the chromatin status (Iwafuchi-
Doi et al., 2016).
Histone Modifications
Histone modifications represent another important mechanism
of epigenetic regulation (Baylin and Jones, 2011). Histone
acetyltransferases (HATs) and histone deacetylases (HDACs)
have been shown to respond to regulatory signals involved
in adipocyte differentiation and adipogenesis (Zhou et al.,
2014). HDAC9 negatively regulated adipogenic differentiation in
HDAC9 overexpression and knockout experiments (Chatterjee
et al., 2011). During chronic high-fat feeding in mice, HDAC9
deletion was shown to offer a protective effect against metabolic
diseases by increasing adiponectin expression (Chatterjee et al.,
2014). Histone deacetylase HDAC4 is repressed in exercise-
induced DNA methylation, leading to a reduced repressive
activity on glucose transporter GLUT4 and thus increasing
adipocyte glucose uptake and lipogeneis (Rönn et al., 2013).
Recent studies have also shown the effect of H3K9 methylation
at Cebpa and Pparg loci marked with H3K4me3 deposition
limits CCATT/enhancer binding protein β binding and thus
halting adipogenesis (Matsumura et al., 2015). Although very
limited studies have been done on histone modification profiling
in adipocytes, more and more evidence is pointing toward
the roles of histone modifiers in adipocyte functions the
pathological development of metabolic diseases. Epigenetic
studies of adipocyte metabolism may shed light on the disease
progression as well as the gender differences in metabolic diseases
and HCC.
Gender Dimorphism in MiRNAs Actions
in Adipocyte Tissue
MicroRNAs (miRNAs) are small noncoding RNAs of 18–
15 nucleotides that regulate the translation of messenger
RNAs (mRNAs) through binding to their 3′-untranslated
regions (UTRs) leading to translation inhibition and/or mRNA
degradation (Wong et al., 2008). miRNAs are known to
be involved in multiple biological functions, including cell
proliferation, cell differentiation, metabolism, and immunity and
in diseases such as cancer, cardiovascular diseases and type
2 diabetes (Mendell, 2005). In adipocytes, the expression of
miRNAs and the corresponding regulation are closely related
to sex hormones androgen and estrogen, providing a promising
scope to understand gender dimorphism in lipid metabolism.
miR-125a/b
The miR-125 family comprises miR-125a and miR-125b with
similar sequences. The miR-125 family has been reported to play a
role in the initiation and progression of cancers by either acting as
tumor suppressors or oncogenes (Cowden Dahl et al., 2009; Jiang
et al., 2010). However, it is clear that miR-125a down-regulation
is clear linked to the development of leukemia (Ufkin et al., 2014).
MiR-125a is also found responsible in adipose tissue and immune
development (Sun et al., 2009; Guo et al., 2010). MiR-125a targets
and inhibits the expression of estrogen-related receptor alpha
(ERRα), a nuclear receptor that plays an important role in a
number of metabolic homeostasis processes, such as fatty acid
metabolism (Huss et al., 2004; Ji et al., 2014). It was also found
that miR-125a is overexpressed in diabetic rats as compared
with non-diabetic ones (Herrera et al., 2009). Intriguingly, the
overexpression of miR-125a has been found to inhibit adipocyte
differentiation and the underlying gender-specific mechanisms
of how miR-125a works together with ERRα requires further
investigation (Herrera et al., 2009). Although the relationship
of miR-125 and estrogen signaling in adipocytes has not been
well established, estrogen is found to alter miR-125 family in
other cell types. MiR-125b can be up-regulated by estrogen via
ERα pathway, which thus protects against NAFLD in mouse
hepatocytes by inhibiting fatty acid synthesis and preventing lipid
accumulation in liver (Zhang et al., 2015) (Table 1).
miR-222
In a study of 3T3-L1 adipocytes, miR-222 was found upregulated
when exposed to a high extracellular glucose concentration
and in obese adipocytes (Xie et al., 2009; Herrera et al.,
2010). High estradiol concentrations in visceral adipocytes were
reported to increase miR-222 expression and decrease ERα and
GLUT4 expression (Shi et al., 2014). Previous findings have
also demonstrated the role of estrogen, androgen, and other
hormones in insulin sensitivity (Livingstone and Collison, 2002;
Retnakaran et al., 2010). High estrogen level can reduce insulin
sensitivity by mediating ERα and ERβ (Barros et al., 2009). In
vivo and in vitro studies indicated that a high concentration
of estrogen could inhibit the expression of the insulin-sensitive
transporter GLUT4 in adipose tissue, muscle, and liver (Campbell
and Febbraio, 2002). ERα was also found to be a direct target
of miR-222 in breast cancer cells, with a specific binding site
at the seed sequence of miR-222 (Rao et al., 2011). miR-222
could be an important regulator of ERα expression in insulin
resistance. However, a clearer pathway needs to be elucidated
by further overexpression of miR-222 to determine whether it
directly acts on ERα and GLUT4 expression (Shi et al., 2014).
Possible signaling pathways of the action of miR-222 includes
β-catenin and TGF-β signaling (Rao et al., 2011) (Table 1).
miR-301a
Preadipocytes can proliferate and differentiate into an adipose
deposit upon stimulation and leads to an increase in adipocyte
numbers and leading to obesity (Rosen and MacDougald, 2006).
Although the relationship between preadipocyte infiltration and
the initiation of HCC remains unclear, studies have shown that
the recruitment of preadipocytes is responsible for enhancing
prostate cancer invasion and breast cancer development (Rama-
Esendagli et al., 2014; Xie et al., 2015). Preadipocytes were found
to induce miR-301a to promote metastasis of prostate cancer by
down-regulating AR (Xie et al., 2015). Down-regulation of AR
could regulate translationally and increase TGF-β1 expression
(Qi et al., 2008). Following the Smad signaling mediators, the
down-regulation of AR consequentially activated target genes
like matrix metallopeptidase 9 (MMP-9) and promote tumor
metastasis (Derynck et al., 1998; Wang et al., 2013). Although
AR overexpression was present in progressive HCC, AR was
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TABLE 1 | Target genes, functions of sex hormone-associated miRNAs in adipocytes.
miRNA Expression
in Obesity
Expression
in T2D
Targets Upstream Functions Reference
miR-125a Up Up Inhibit ERRα ? Inhibit adipocyte differentiation;
Inhibit ERRα;
Reduce insulin sensitivity
Huss et al., 2004; Herrera et al.,
2009; Sun et al., 2009; Guo
et al., 2010; Ji et al., 2014; Yeh
et al., 2014
miR-125b Down Down ? Up-regulated
by ERα
Inhibit NAFLD;
Inhibit lipid accumulation;
Inhibit fatty acid synthesis
Xie et al., 2009; Ortega et al.,
2010; Zhang et al., 2015
miR-222 Up Up Inhibit ERα,
GLUT4
Up-regulated by
high glucose
and estradiol
Reduce insulin sensitivity Campbell and Febbraio, 2002;
Livingstone and Collison, 2002;
Xie et al., 2009; Herrera et al.,
2010; Retnakaran et al., 2010;
Rao et al., 2011; Shi et al.,
2014; Deiuliis, 2016
miR-301a ? Up Inhibit AR ? Promote metastasis;
Increase TGF-β1 expression
Derynck et al., 1998; Qi et al.,
2008; Panguluri et al., 2013;
Xie et al., 2015
miR-375 Down Down Inhibit
ADIPOR2
Induced by
ERK-PPARg-aP2
signaling;
Inhibited by
androgen
Promote fat accumulation;
Reduce insulin sensitivity
Yamauchi et al., 2003; Krek
et al., 2005; Bauer et al., 2010;
Ling et al., 2011; Kraus et al.,
2015
also found to be essential in suppressing HCC metastasis in
the later stage of tumor development (Zender and Kubicka,
2008; Ma et al., 2012). A high AR expression could reduce the
phosphorylation and inhibit the activity of p38, NF-κB signaling
and MMP-9 expression and the suppress HCC metastasis (Tian
et al., 2015). The coinciding evidence of miR-301a expression and
AR signaling in preadipocytes in different cancer types may help
understand the gender disparity of late-stage HCC progression
(Table 1).
miR-375
The direct binding of miR-375 was mentioned to locate at the 3′-
UTR of murine and human ADIPOR2 (Krek et al., 2005; Kraus
et al., 2015). ADIPOR2, as a receptor for adiponectin, mediates
to increased PPARα ligand activities and fatty-acid oxidation
by regulating adiponectin and ADIPOR2 signaling in adipose
tissue (Yamauchi et al., 2003; Bauer et al., 2010). The function
of miR-375 was reported to be induced during adipogenesis
and to promote adipocyte differentiation by suppressing ERK1/2
phosphorylation via the ERK-PPARg-aP2 signaling (Ling et al.,
2011). Insulin resistance in adipocytes was associated with a
low adiponectin receptor level (Bauer et al., 2010). Increased
expression levels of both ADIPOQ and ADIPOR2 could help
prevent fat accumulation in liver and adipose tissue and led to
increased insulin sensitivity (Ma and Liu, 2013). Studies also
showed that the expressions of adipogenesis-promoting miR-
375 and ADIPOR2 were decreased and increased, respectively,
in androgen treatment (Kraus et al., 2015). Inhibiting miR-375
could decrease adipocyte differentiation and increase ADIPOR2
protein expression (Kraus et al., 2015). From the observations in
separate studies, mR-375 may be responsible for the deterioration
of insulin-resistance-related liver injury and may cause the
difference in the visceral fat deposition and liver diseases in men
and women when the body androgen level decreases with age
(Bassil et al., 2009) (Table 1).
Emerging epigenetic studies in adipocytes reveal a range of
regulatory mechanisms in adipogenesis, adipokine expression
and other metabolic pathways. Although limited studies have
been done in the epigenetic regulations in adipocytes to
demonstrate gender dimorphisms, AR and ER have already been
shown to alter the epigenetic profiles as a nuclear factor in HCC
cells (Li et al., 2012). Our body fat composition may as well
be regulated epigenetically and lead to such gender disparities.
The epigenetic mechanisms in adipocytes may provide insights
in HCC development through metabolic deregulation. With the
advancement of the nuclei capture technique in VAT and SCAT
mentioned by Ambati et al. (2016) it will be promising to study
the depot-specific and even gender-specific epigenetic profiles
in adipocytes to unveil the underlying mechanisms in adipocyte
homeostasis and its potential effects on HCC initiation.
GENDERS, AQUAGLYCEROPORINS and
HCC
Glycerol-3-phosphate (G3P), which is also known as glycerol,
is an important metabolite for the control of fat accumulation
and is the responsible for triacylglycerols (TAGs) synthesis
and glucose homeostasis. Circulating free glycerol results from
lipolysis, diets or in the kidney reabsorption (Reshef et al.,
2003). Aquaglyceroporins (AQPs) are protein channels for the
transport of glycerol, other small neutral solutes and water
across adipocytes. AQPs are emerging as important players
adipocyte homeostasis implicated with adiposity and the control
of insulin resistance (Rojek et al., 2007). Aquaglyceroporins are
sub-classified into AQP3, 7, 9, and 10 which regulate transport of
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glycerol and insulin sensitivity in adipocytes (Frühbeck, 2005). In
line with the gender dimorphisms in glucose and fat metabolism,
the different expressions of AQPs and glycerol transport in men
and women are also observed in diet-induced diseases including
insulin resistance and NAFLD (Rodríguez et al., 2006; Rojek et al.,
2007).
Regarding the relationship between AQPs and HCC, emerging
evidence has also been ascribing AQP deregulation in hepatocytes
to the pathogenesis and, as well, the metastasis of NAFLD-
associated HCC. AQP9 has been identified as an important
glycerol transport pathway in hepatocytes to facilitate hepatic
gluconeogenesis and TAG synthesis (Rodríguez et al., 2011a).
AQP9 is the main aquaglyceroporin in the liver and is
dramatically reduced in HCC and is localized at non-tumorigenic
liver tissue (Padma et al., 2009; Ribatti et al., 2014; Chen et al.,
2016). AQP9 knockdown in mice significantly alleviated NAFLD-
related symptoms including intrahepatic lipid accumulation and
high serum lipid level, possibly due to a decrease in glycerol
import into hepatocytes thus reducing liver lipid accumulation
(Cai et al., 2013). The results are controversial since the resulted
AQP9 knockdown is not tissue-specific and a global effect
of AQP9 is observed, including glycerol absorption. However,
AQP9 down-regulation was found frequent in hepatic biopsies
of obese patients with type 2 diabetes (Catalán et al., 2008).
A reduced AQP9 expression in HCC cells was shown to
resist apoptosis and the respective overexpression could restore
the cell responsiveness to apoptotic stimuli (Jablonski et al.,
2007). Protein kinase A activator, dibutyrul cAMP, increased
AQP9 expression in HCC cells and suppressed tumor growth
in vivo, suggesting the important roles of hepatocyte AQP9
in HCC development (Peng et al., 2016). Experiments in the
SMMC7721 cell line demonstrated the molecular mechanism
of AQP overexpression on its tumor suppressive function. An
increase in AQP9 expression repressed the PI3K/Akt pathway
and thus increased forkhead box protein O1 expression and up-
regulation of apoptotic caspase-3 (Li et al., 2016; Zhang Q. et al.,
2016). AQP9 downregulation also promoted HCC metastasis in
mice (Zhang Q. et al., 2016). The observed down-regulation of
AQP9 in hepatocytes in obesity, diabetes and HCC is believed to
be a negative feedback response of high glycerol intake. AQP9 is
important in controlling glycerol import in hepatocytes. A proper
glycerol import is crucial in maintaining the gluconeogenic
pathway in hepatocytes and a normal lipid metabolism in the
surrounding adipose tissues. The up-regulation hepatic AQP9
expression was associated with the alleviation the NAFLD-
associated symptoms (Rodríguez et al., 2015b). AQP9 in
hepatocytes is considered to offer a protective effect on HCC
initiation and metastasis. On top of the clear relationship between
hepatocyte AQPs with HCC, the interactions between adipocytes
and hepatocytes are crucial in studying NAFLD-related HCC
development since the distinguishing difference in fat deposition
in males and females also affect glycerol transport and the
corresponding subsequences. The coinciding gender dimorphism
in fat metabolism and HCC development show the prospect in
the interrelation between adipocyte and hepatocyte homeostasis.
In adipocytes, AQP7 acts as the main pathway in facilitating
release of glycerol, while the others, including AQP3, 10 and 11
contribute glycerol export to a lower extent (Rodríguez et al.,
2011a; Laforenza et al., 2013; Madeira et al., 2014). The expression
of AQPs also appears to be location-specific. Visceral adipocytes
exhibit a higher expression level of AQP3 and AQP7, which may
result in the overall rise in the lipolytic rate and glycerol release
from VAT (Miranda et al., 2010; Rodríguez et al., 2015a). In
contrast, subcutaneous fat with a lower AQP7 level may help
promote glycerol accumulation and thus adipocyte hypertrophy
(Rodríguez et al., 2015a). AQP regulation in adipocytes is crucial
in maintain the fat and glucose homeostasis, i.e., a deregulation
will lead to obesity and insulin resistance (Kuriyama et al., 2002;
Hibuse et al., 2005).
A higher plasma glycerol level can be observed in females,
which can be explained by a higher body fat rate resulting
in a faster glycerol turnover (Hedrington and Davis, 2015).
Moreover, adipose tissues respond differently to adipokines,
lipolytic hormones and probably sex hormones in men and
women (Schmidt et al., 2014). Fasting studies and exercise
studies have shown that women exhibit a significantly higher
glycerol level than men, which may be ascribed to the differences
in sensitivity to insulin, epinephrine, leptin and even neural
activities (Clore et al., 1989; Davis et al., 2000; Frühbeck et al.,
2001, 2014; Hedrington and Davis, 2015). Obesity is associated
with a higher lipolytic rate, plasma FFAs and glycerol (Rodríguez
et al., 2015a). A gender-specific effect of regular exercise has
shown a higher expression of omental adipose AQP7 in females
(Rodríguez et al., 2015a).
Besides differential AQP expression, gender dimorphisms also
occur in the response to leptin. The adipokine leptin has a
lipolytic activity and has been shown to repress AQP7 and
AQP9 expression via the PI3K/Akt/mTOR signaling pathway
in human adipocytes (Rodríguez et al., 2011b). The association
between a higher expression of AQP7 in females and the
leptin level requires further investigation (Sjöholm et al., 2005;
Dahlhoff et al., 2014). Leptin stimulates translocation of AQP7
to the cytoplasm to facilitate glycerol release from adipocytes
(Rodríguez et al., 2015b). At the same time leptin can also
downregulates AQP7 mRNA to prevent depletion of fat stores
(Rodríguez et al., 2015b). Long-term leptin administration in
male leptin-deficit mice could downregulate AQP3 and AQP7
could help alleviate lipid accumulation in adipose tissue and liver
(Rodríguez et al., 2011b, 2015b). However, the miscellaneous
functions of leptin contradict in the development of obesity
and liver cancer (Rodríguez et al., 2015b). The rescuing effect
of leptin in NAFLD in leptin-deficient obese mice could be
due to the neuroactive effects of leptin, but not as adipokines
promoting local inflammation around internal organs. AQP7
is downregulated in women with severe obesity and this trait
is limited to obesity but not type 2 diabetes (Ceperuelo-
Mallafré et al., 2007). The downregulation of AQP7 was also
reported to increase susceptibility of obesity by promoting lipid
accumulation in the adipose tissue (Marrades et al., 2006). The
complicated association between NAFLD and AQPs involve
not only adipocyte glycerol transport, but also the glucose and
glycerol transport in hepatocytes. Mechanistic delineation of
leptin in adipocytes is required to elucidate its relationship with
liver cancer initiation.
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CONCLUDING REMARKS
Deregulated energy homeostasis and metabolic disorders
induced by obesity and type 2 diabetes are key but largely
unresolved issues in HCC development. The alterations in
genetic, epigenetic and miRNA control of lipid and glucose
metabolism, oxidative stress and the production of pro-
inflammatory and anti-inflammatory cytokines contribute to
the multiple-step development of NAFLD, NASH, cirrhosis and
eventually HCC. The increased incidence of HCC associated
with metabolic syndrome is significantly associated with
the male gender. Sexual dimorphism as exemplified by the
androgen and estrogen signaling pathways shapes the fat
distribution in the body, contributing to the differential
exposure to pro-inflammatory cytokines and lipotoxic adipokines
which influence hepatic malignant transformation. Further
mechanistic delineation of adipocyte metabolism via sex
hormones using systems approach will shed light on the
multifaceted roles of aberrant fat accumulation in HCC initiation
and progression.
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